inSignals Neurotech
Porto
About inSignals Neurotech
inSignals Neurotech is a spin-off of the R&D Institute INESC TEC, that brings to market solutions developed by the research group. The company will explore technologies based on microengineering that enhance therapeutics approaches when dealing with neurological pathologies. The products being developed are designed after hearing the demands from doctors that require solutions to improve the precision of motor symptoms analysis, to support better therapeutics. The first product that will enter the market is iHandU to evaluate motor rigidity objectively and support Deep Brain Stimulation therapy of patients with Parkinson’s Disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $121.3K
- Funding stage: Seed
- Last round: Seed (Feb 2021)
- Website: insignals-neurotech.com
Industries & Categories
Health Care, Life Science, Neuroscience
Canonical: https://fsome.com/organization/insignals-neurotech-9904 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.